Patent ID: 7985560
Filing Date: 2011-07-26
Classification: G01N

Abstract:
1. A method of assigning a risk of an adverse outcome to a patient suffering from heart failure, comprising: performing two or more of the assay methods in steps (a)-(d) below: a. an assay method that detects NGAL on a body fluid sample obtained from said patient, thereby providing an NGAL assay result; b. an assay method that detects one or more of BNP, NT-proBNP and proBNP on a body fluid sample obtained from said patient, thereby providing a natriuretic peptide assay result; c. an assay method that detects cystatin C on a body fluid sample obtained from said patient, thereby providing a cystatin C assay result; d. an assay method that detects serum creatinine on a body fluid sample obtained from said patient, thereby providing a serum creatinine assay result; and correlating the assay results obtained to said risk of an adverse outcome.